Evidence map›Paper›PMID 28196272›Full record

ArticleAlcoholism, clinical and experimental research2017

Deep Sequencing of 71 Candidate Genes to Characterize Variation Associated with Alcohol Dependence.

Shaunna L Clark, Joseph L McClay, Daniel E Adkins, Gaurav Kumar, Karolina A Aberg, Srilaxmi Nerella, Linying Xie, Ann L Collins, James J Crowley, Corey R Quackenbush and 12 more

Open access · greenAbstract readTwin Study
In one paragraph

Article in Alcoholism, clinical and experimental research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 6 institutions in 2 countries.

Shaunna L ClarkCenter for Biomarker Research and Precision Medicine , School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia.
Joseph L McClayCenter for Biomarker Research and Precision Medicine , School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia.
Daniel E AdkinsCenter for Biomarker Research and Precision Medicine , School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia.
Gaurav KumarCenter for Biomarker Research and Precision Medicine , School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia.
Karolina A AbergCenter for Biomarker Research and Precision Medicine , School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia.
Srilaxmi NerellaCenter for Biomarker Research and Precision Medicine , School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia.
Linying XieCenter for Biomarker Research and Precision Medicine , School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia.
Ann L CollinsDepartment of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
James J CrowleyDepartment of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Corey R QuackenbushDepartment of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Christopher E HilliardDepartment of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Andrey A ShabalinCenter for Biomarker Research and Precision Medicine , School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia.
Scott I VriezeDepartment of Psychology and Neuroscience, Institute for Behavioral Genetics, University of Colorado Boulder, Boulder, Colorado.
Roseann E PetersonVirginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, Virginia.
William E CopelandDepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina.
Judy L SilbergVirginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, Virginia.
Matt McGueDepartment of Psychology, University of Minnesota, Minneapolis, Minnesota.
Hermine MaesVirginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, Virginia.
William G IaconoDepartment of Psychology, University of Minnesota, Minneapolis, Minnesota.
Patrick F SullivanDepartment of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Elizabeth J CostelloDepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina.
Edwin J van den OordCenter for Biomarker Research and Precision Medicine , School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia.
Virginia Commonwealth University · USUniversity of North Carolina at Chapel Hill · USUniversity of Minnesota · USDuke Medical Center · USDuke University Hospital · USUniversity of Colorado Boulder · US

Funding

TWIN STUDY OF FEMALE ALCOHOLISMS AND OTHER DISORDERSR01AA009367 · NIAAA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MCGUE, MATTHEW K. · 1992 to 2013
$9.0M
Twin Family Study of Vulnerability to Substance AbuseR37DA005147 · NIDA · UNIVERSITY OF MINNESOTA · PI IACONO, WILLIAM G. · 2009 to 2018
$6.4M
TWIN/FAMILY STUDY OF VULNERABILITY TO SUBSTANCE ABUSER01DA005147 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI IACONO, WILLIAM G · 1987 to 2007
$5.5M
Adolescent drinking and midlife outcomes: A prospective cotwin control studyR37AA009367 · NIAAA · UNIVERSITY OF MINNESOTA · PI MCGUE, MATTHEW K. · 2016 to 2024
$5.4M
Research Education in Statistical Genetics of Substance AbuseR25DA026119 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI NEALE, MICHAEL CHURTON · 2008 to 2018
$3.2M
Adult consequences of youth substance use: Twin study enriched for SUD riskR01DA036216 · NIDA · UNIVERSITY OF MINNESOTA · PI IACONO, WILLIAM G. · 2013 to 2017
$3.2M
Substance Abuse & Behavioral Disinhibition: Integrating Genes & EnvironmentR01DA024417 · NIDA · UNIVERSITY OF MINNESOTA · PI IACONO, WILLIAM G. · 2011 to 2011
$1.6M
Developmental Genetic Epidemiology of PsychopathologyR01MH068521 · NIMH · VIRGINIA COMMONWEALTH UNIVERSITY · PI EAVES, LINDON J · 2003 to 2006
$1.3M
A Developmental Model of Gene-Environment Interplay in SUDsR01DA024413 · NIDA · DUKE UNIVERSITY · PI COSTELLO, ELIZABETH JANE · 2011 to 2011
$1.2M
Early Substance Use in Rural American Indian and White/Anglo YouthR01DA036523 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COPELAND, WILLIAM · 2014 to 2016
$700k
Investigating Methylation Patterns Associated with Alcohol Use and AddictionK01AA021266 · NIAAA · VIRGINIA COMMONWEALTH UNIVERSITY · PI CLARK, SHAUNNA L · 2012 to 2016
$580k
NIAAA NIH HHS K01 AA021266NIAAA NIH HHS R01 AA009367NIAAA NIH HHS R37 AA009367NIDA NIH HHS R01 DA005147NIDA NIH HHS R01 DA024413NIDA NIH HHS R01 DA024417NIDA NIH HHS R01 DA036216NIDA NIH HHS R01 DA036523NIDA NIH HHS R25 DA026119NIDA NIH HHS R37 DA005147NIMH NIH HHS R01 MH068521
6 · The paper itself

Abstract

backgroundPrevious genomewide association studies (GWASs) have identified a number of putative risk loci for alcohol dependence (AD). However, only a few loci have replicated and these replicated variants only explain a small proportion of AD risk. Using an innovative approach, the goal of this study was to generate hypotheses about potentially causal variants for AD that can be explored further through functional studies.

methodsWe employed targeted capture of 71 candidate loci and flanking regions followed by next-generation deep sequencing (mean coverage 78X) in 806 European Americans. Regions included in our targeted capture library were genes identified through published GWAS of alcohol, all human alcohol and aldehyde dehydrogenases, reward system genes including dopaminergic and opioid receptors, prioritized candidate genes based on previous associations, and genes involved in the absorption, distribution, metabolism, and excretion of drugs. We performed single-locus tests to determine if any single variant was associated with AD symptom count. Sets of variants that overlapped with biologically meaningful annotations were tested for association in aggregate.

resultsNo single, common variant was significantly associated with AD in our study. We did, however, find evidence for association with several variant sets. Two variant sets were significant at the q-value <0.10 level: a genic enhancer for ADHFE1 (p = 1.47 × 10

conclusionsTo our knowledge, this is the first sequencing study of AD to examine variants in entire genes, including flanking and regulatory regions. We found that in addition to protein coding variant sets, regulatory variant sets may play a role in AD. From these findings, we have generated initial functional hypotheses about how these sets may influence AD.

Indexed as

AdultAlcoholismFemaleGenetic Association StudiesGenetic VariationHigh-Throughput Nucleotide SequencingHumansMaleSequence Analysis, DNAYoung AdultAlcohol DependenceAldehyde DehydrogenaseGeneticsNext-Generation SequencingSerotoninSNP

Identifiers

PMID28196272
PMCPMC5378639
OpenAlexW2588858596

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.